<DOC>
	<DOCNO>NCT02227771</DOCNO>
	<brief_summary>The purpose study demonstrate enhance vascular healing Synergy stent minimize risk late aneurysm formation potential clinical complication cost enhance efficacy .</brief_summary>
	<brief_title>Consistent CTO Trial</brief_title>
	<detailed_description />
	<criteria>Male female patient &gt; 18 year old Females childbearing potential negative pregnancy test Presence Chronic Total Occlusion ( CTO ) know presume least 3 month duration Subject ( legal guardian ) understand trial requirement treatment procedure provide write informed consent Attempt implant least one Synergy II stent make Acute myocardial infarction ongoing STelevation Cardiogenic shock Left ventricular ejection fraction &lt; 20 % Subject one following ( assess prior index procedure ) : Other serious medical illness ( e.g. , cancer , congestive heart failure ) estimate life expectancy le 24 month Current problem substance abuse ( e.g. , alcohol , cocaine , heroin , etc . ) Planned procedure may cause noncompliance protocol confound data interpretation Subject treat dialysis baseline serum creatinine level &gt; 220 Î¼mol/L ( 2.5 mg/dL ) Known allergy contrast ( adequately premedicated ) and/or trial stent system protocolrequired concomitant medication ( e.g. , platinum , platinumchromium alloy , stainless steel , everolimus structurally related compound , polymer individual component , P2Y12 inhibitor , aspirin ) Subject participate another investigational drug device clinical trial reach primary endpoint OR subject intend participate another investigational drug device clinical trial within 12 month index procedure Need ongoing longterm anticoagulation Subject receive organ transplant wait list organ transplant Subject receiving schedule receive chemotherapy within 30 day index procedure Planned CABG index procedure Subject previously treat time intravascular brachytherapy Subject platelet count &lt; 100,000 cells/mm3 &gt; 700,000 cells/mm3 Subject white blood cell ( WBC ) count &lt; 3,000 cells/mm3 Subject document suspect liver disease , include laboratory evidence hepatitis Subject clinically significant bleed diathesis coagulopathy refuse blood transfusion Subject history cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) within past 6 month Subject active peptic ulcer active gastrointestinal ( GI ) bleed Subject severe symptomatic heart failure ( i.e. , NYHA class IV ) Subject know intention procreate within 12 month index procedure ( woman childbearing potential sexually active must agree use reliable method contraception time screen 12 month index procedure ) Subject woman pregnant nursing ( pregnancy test must perform within 7 day prior index procedure woman childbearing potential )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>